ClinicalTrials.Veeva
Menu

Find clinical trials for Endometrial Cancer in Salt Lake City, UT

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Ovarian Cancer
Non-Small-Cell Lung Carcinoma
Breast Cancer
Colorectal Cancer
Cancer
Uterine Cervical Cancer
Stomach Cancer

Endometrial Cancer trials near Salt Lake City, UT, USA:

Abemaciclib and Letrozole to Treat Endometrial Cancer

letrozole in advanced stage, persistent or recurrent endometrioid endometrial cancer at 6 months. Treatment will continue until eit...

Active, not recruiting
Endometrial Cancer
Drug: Letrozole
Drug: Abemaciclib

Phase 2

Gynecologic Oncology Group (GOG)

Salt Lake City, Utah, United States and 28 other locations

in treating patients with recurrent or progressive uterine endometrial cancer after platinum-based chemotherapy and immune checkpoi...

Begins enrollment this month
Uterine Endometrial Cancer
Drug: TUB-040 - Dose escalation
Drug: TUB-040 - RP2D

Phase 1, Phase 2

Tubulis

West Valley City, Utah, United States and 3 other locations

The study is divided into two cohorts (Cohort 1 and Cohort 2), to which participants will be enrolled based on the amount of human epidermal growth f...

Enrolling
Endometrial Cancer
Drug: Doxorubicin
Drug: Docetaxel

Phase 3

BioNTech
BioNTech

Murray, Utah, United States and 190 other locations

to evaluate the efficacy and safety of ACR-368 as monotherapy or with ultra-low dose gemcitabine (ULDG) sensitization in participants with endometrial...

Enrolling
Endometrial Adenocarcinoma
Drug: ACR-368
Diagnostic Test: OncoSignature

Phase 2

Acrivon Therapeutics

Salt Lake City, Utah, United States and 89 other locations

to Part A (Phase 1a and Phase 1b) will include ovarian and endometrial cancers. Enrollment to Part B (Phase 1a and Phase 1b) will i...

Enrolling
Endometrial Cancer
Platinum Resistant Ovarian Cancer
Drug: HWK-016, MUCIN-16-targeted ADC
Drug: Bevacizumab

Phase 1

Whitehawk Therapeutics, Inc.

Salt Lake City, Utah, United States and 11 other locations

in participants with solid tumors.Participants will have solid tumor cancer that has spread through the body (metastatic) or cannot be remov...

Enrolling
Uterine Cancer
Hormone Receptor-positive/Her2 Negative Breast Cancer
Drug: Carboplatin
Drug: Pembrolizumab

Phase 1, Phase 2

Genmab
Genmab

West Valley City, Utah, United States of America and 65 other locations

The purpose of this study is to characterize the safety, tolerability, and efficacy of IDE161 as a single agent and in combination with pembrolizumab.

Active, not recruiting
Endometrial Cancer
Extensive Stage Small Cell Lung Cancer (ES-SCLC)
Drug: Pembrolizumab
Drug: IDE-161

Phase 1

Ideaya Biosciences

West Valley City, Utah, United States of America and 26 other locations

This is a Phase 1, two-part, open-label, nonrandomized, dose-escalation and signal-seeking study of CGT6297, evaluating the safety, tolerability, PK,...

Enrolling
Endometrial Cancer
HER2-low Breast Cancer
Drug: CGT6297

Phase 1

Cogent Biosciences

West Valley City, Utah, United States and 10 other locations

The goal of the Dose Escalation phase of the study is to evaluate the safety, tolerability, pharmacokinetics (PK) and preliminary anti-tumor activity...

Enrolling
Small Cell Lung Cancer
Platinum-resistant Ovarian Cancer
Drug: NKT3964

Phase 1

NiKang Therapeutics

Salt Lake City, Utah, United States and 18 other locations

-small-cell lung cancer (NSCLC), triple negative breast cancer (TNBC), ovarian cancer (OC), endometrial cancer...

Active, not recruiting
Castration-resistant Prostate Cancer
Lower Esophageal Cancer
Drug: cabozantinib
Drug: atezolizumab

Phase 1

Exelixis
Exelixis

Salt Lake City, Utah, United States and 123 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems